Literature DB >> 29102975

Fatal delayed haemolytic transfusion reaction in a patient without previous transfusions but with an obstetric history of 13 pregnancies.

Evgeni Chubar1, Naiel Bisharat1.   

Abstract

Delayed haemolytic transfusion reaction is a rare, life-threatening complication of blood transfusion that has been typically described among patients with sickle cell disease (SCD) due to alloimmunisation induced by their exposure to red blood cell antigens through recurrent transfusions. We report the case of a patient who suffered from fatal delayed haemolytic transfusion reaction (DHTR) occurring 1 week after blood transfusion. Indirect antiglobulin testing confirmed the presence of anti-Kell antibodies that were absent in the pretransfusion sample. The patient did not receive blood transfusions in the past, but her obstetric history was remarkable for 13 pregnancies. Although DHTR occurs more commonly among patients with SCD, this type of reaction can occur in any patient who is able to mount an immune response. We would to like to draw the attention of physicians to this rare and potentially lethal complication of blood transfusion, especially in grand multiparous women. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); obstetrics and gynaecology

Mesh:

Year:  2017        PMID: 29102975      PMCID: PMC5747803          DOI: 10.1136/bcr-2017-222343

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review.

Authors:  Amr El-Husseini; Alaa Sabry
Journal:  Am J Emerg Med       Date:  2010-11       Impact factor: 2.469

Review 2.  Mechanisms of suicidal erythrocyte death.

Authors:  Karl S Lang; Philipp A Lang; Christian Bauer; Christophe Duranton; Thomas Wieder; Stephan M Huber; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2005

3.  Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

Authors:  F Pirenne; P Bartolucci; A Habibi
Journal:  Transfus Clin Biol       Date:  2017-06-29       Impact factor: 1.406

Review 4.  Transfusion reactions: prevention, diagnosis, and treatment.

Authors:  Meghan Delaney; Silvano Wendel; Rachel S Bercovitz; Joan Cid; Claudia Cohn; Nancy M Dunbar; Torunn O Apelseth; Mark Popovsky; Simon J Stanworth; Alan Tinmouth; Leo Van De Watering; Jonathan H Waters; Mark Yazer; Alyssa Ziman
Journal:  Lancet       Date:  2016-04-12       Impact factor: 79.321

5.  Transfusion reaction. An immunologic hazard of blood transfusion.

Authors:  A A Pineda; H F Taswell; S M Brzica
Journal:  Transfusion       Date:  1978 Jan-Feb       Impact factor: 3.157

6.  Fatal delayed hemolytic transfusion reaction without previous blood transfusion.

Authors:  T F Schorn; W H Knospe
Journal:  Ann Intern Med       Date:  1989-02-01       Impact factor: 25.391

7.  The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.

Authors:  P M Ness; R S Shirey; S K Thoman; S A Buck
Journal:  Transfusion       Date:  1990-10       Impact factor: 3.157

Review 8.  How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.

Authors:  Kate Gardner; Carolyn Hoppe; Aleksandar Mijovic; Swee L Thein
Journal:  Br J Haematol       Date:  2015-05-13       Impact factor: 6.998

Review 9.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

10.  A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion.

Authors:  N M Heddle; R L Soutar; P L O'Hoski; J Singer; J A McBride; M A Ali; J G Kelton
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

View more
  1 in total

1.  An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jkb and Anti-Fya Alloantibodies.

Authors:  Kenza El Alaoui; Fleur Samantha Benghiat; Martin Colard
Journal:  J Hematol       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.